MPO - myeloperoxidase Gene
Species: Felis catus
Gene Type: protein coding
Gene ID: 100142673
MPO Products (1)
| mRNA | Protein | Name |
|---|---|---|
| NM_001122746.2 | NP_001116218.2 | myeloperoxidase precursor |
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
myeloperoxidase |
|
Related Agents
- Approval
- Clinical Phase
- Pre-clinical Phase
Approval
Bioactive Molecules
(3)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-B0679 | Lubiprostone | 99.09% | Yes | |
| HY-B0174 | Olsalazine Disodium | Inducer | 99.82% | Unkown |
| HY-B0174A | Olsalazine | Inducer | 99.83% | Unkown |
Clinical Phase
Bioactive Molecules
(8)
| Cat. No. | Product Name |
Effect
|
Purity |
Phase |
|---|---|---|---|---|
| HY-D3224 | HCP | / | Phase 4 | |
| HY-145581 | Mitiperstat | Inhibitor | 99.12% | Phase 3 |
| HY-17646 | Verdiperstat | Inhibitor | 99.69% | Phase 3 |
| HY-106228 | HLF1-11 | Inhibitor | 99.73% | Phase 2 |
| HY-105017 | Evodenoson | Agonist | 99.94% | Phase 2 |
| HY-133931 | Bimakalim | / | Phase 2 | |
| HY-19205A | CMI-392 | / | Phase 2 | |
| HY-111341 | AZD5904 | Inhibitor | 99.93% | Phase 1 |
Pre-clinical Phase
Bioactive Molecules
(49)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-B0880 | 4-Aminobenzohydrazide | Inhibitor | 99.96% | Unkown |
| HY-114360 | Taurohyodeoxycholic acid | Inhibitor | 99.73% | Unkown |
| HY-100873 | PF-1355 | Inhibitor | 99.80% | Unkown |
| HY-N7700A | Guluronic acid sodium | Inhibitor | 98.0% | Unkown |
| HY-N6937 | (R,R)-Secoisolariciresinol diglucoside | 99.21% | Unkown | |
| HY-N6066 | Praeruptorin E | 99.83% | Unkown | |
| HY-125859A | Myeloperoxidase, human white blood cells | Inhibitor | / | Unkown |
| HY-125039 | N-Acetyl lysyltyrosylcysteine amide | Inhibitor | 99.81% | Unkown |
| HY-115486 | MPO-IN-28 | Inhibitor | 98.11% | Unkown |
| HY-W011168 | 8-Bromo-2'-deoxyguanosine | 98.0% | Unkown | |
| HY-145197 | MPO-IN-3 | Inhibitor | 99.17% | Unkown |
| HY-N11552 | Sorbifolin | Inhibitor | 99.62% | Unkown |
| HY-N6928 | Mogroside III-E | Inhibitor | 99.30% | Unkown |
| HY-W996116 | AZM198 | Inhibitor | 98.40% | Unkown |
| HY-139915 | MPO-IN-1 | Inhibitor | 98.07% | Unkown |
| HY-N4280 | 7,8-Dimethoxycoumarin | Inhibitor | 99.75% | Unkown |
| HY-132132 | Neutrophil elastase inhibitor 3 | Inhibitor | 97.23% | Unkown |
| HY-116188 | HX1 | 99.86% | Unkown | |
| HY-N7700 | Guluronic acid | Inhibitor | 98.90% | Unkown |
| HY-108127 | NAA-004 | Inhibitor | / | Unkown |
| HY-115828 | APA-APA-MPO dihydrochloride | / | Unkown | |
| HY-115829 | APA-H-MPO hydrochloride | / | Unkown | |
| HY-126017 | Aminopyridine 2 | Inhibitor | / | Unkown |
| HY-145581B | (rac)-Mitiperstat | Inhibitor | 98.25% | Unkown |
| HY-145581S | Mitiperstat-d3 | Inhibitor | / | Unkown |
| HY-146651 | MPO-IN-4 | Inhibitor | / | Unkown |
| HY-147691 | MPO-IN-5 | Inhibitor | / | Unkown |
| HY-147692 | COX-2-IN-14 | Inhibitor | / | Unkown |
| HY-163335 | MPO-IN-7 | Inhibitor | / | Unkown |
| HY-168002 | MPO-IN-8 | Inhibitor | / | Unkown |
| HY-173596 | SNT-8370 | Inhibitor | / | Unkown |
| HY-175985 | MPO-IN-9 | Inhibitor | / | Unkown |
| HY-182060 | PDE4B/D-IN-5 | / | Unkown | |
| HY-183367 | Anti-inflammatory agent 115 | Inhibitor | / | Unkown |
| HY-186046 | MPO-IN-10 | Inhibitor | / | Unkown |
| HY-B0174AS | Olsalazine-13C6 | Inducer | / | Unkown |
| HY-B0174AS2 | Olsalazine-d3,15N | Inducer | / | Unkown |
| HY-B0174AS3 | Olsalazine-d6 | / | Unkown | |
| HY-N6937S1 | (R,R)-Secoisolariciresinol diglucoside-d6 | / | Unkown | |
| HY-N8529 | Eupalestin | Inhibitor | / | Unkown |
| HY-P11916 | VH9 | / | Unkown | |
| HY-RS08621 | MPO Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-W767399 | 8-Bromo-2'-deoxyguanosine-13C,15N2 | / | Unkown | |
| HY-103388 | NCX 466 | Inhibitor | / | Unkown |
| HY-163332 | MPO-IN-6 | Inhibitor | / | Unkown |
| HY-19205B | (2S,5S)-CMI-392 | / | Unkown | |
| HY-B0679S | Lubiprostone-d7 | / | Unkown | |
| HY-RS16618 | Mpo Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS23053 | Mpo Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
Inhibitory Antibodies
(2)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-P990181 | Anti-Mouse myeloperoxidase/MPO Antibody (6G4) | Inhibitor | 97.00% | Unkown |
| HY-P990812 | Anti-Mouse myeloperoxidase/MPO Antibody (6D1) | Inhibitor | 99.71% | Unkown |